Knuettel Francis II

CIK 1433316 · CFO, Treas & Secty · last filed 2026-06-10

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$759.7K

Companies

8

Total Filings

37

Lifetime Open-Market Net

-$1.7K

Filer Profile

Reported Address
205 NEWBURY ST
SUITE 204
FRAMINGHAM, MA 01701
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SBEV Director $0.47 $0 1 2026-06-10
BLNE Director 80,000 $1.03 $82.4K $0 3 2026-06-01
PTHS CFO, Treas & Secty 30,841 $21.90 $675.4K -$40.3K 3 2026-05-26
Pelthos Therapeutics Inc. (CHRO) Delisted CEO, Pres., CFO, Treas & Secty 107,822 $13.50 $1.46M $16.0K 7 2025-04-15
FORUM MARKETS Inc (ATNFW) Delisted Director 0 $0.43 $0 $0 3 2023-09-08
SCWorx Corp. (WORX) Delisted Director 23 $5.40 $124 $0 2 2019-11-29
AQMS Chief Financial Officer 813 $2.31 $1.9K $22.6K 1 2018-06-18
MARA CHIEF FINANCIAL OFFICER $11.98 $0 1 2014-11-05

Recent Filings · Page 2 of 4

37 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-09-16 Pelthos Therapeutics Inc. (CHRO) Delisted Buy (P) +5,200 $5.0K EDGAR
2024-09-12 Pelthos Therapeutics Inc. (CHRO) Delisted Buy (P) +12,000 $11.0K EDGAR
2024-07-02 Pelthos Therapeutics Inc. (CHRO) Delisted Gift (G) −20,000 $0 EDGAR
2024-06-18 Pelthos Therapeutics Inc. (CHRO) Delisted Grant (A) $0 EDGAR
2024-06-18 Pelthos Therapeutics Inc. (CHRO) Delisted Grant (A) $0 EDGAR
2024-02-23 Pelthos Therapeutics Inc. (CHRO) Delisted Grant (A) $0 EDGAR
2023-09-08 FORUM MARKETS Inc (ATNFW) Delisted Grant (A) $0 EDGAR
2022-05-23 FORUM MARKETS Inc (ATNFW) Delisted Grant (A) $0 EDGAR
2021-08-05 FORUM MARKETS Inc (ATNFW) Delisted Grant (A) $0 EDGAR
2021-07-12 Grant (A) +1,500,000 $0
Showing 1120 of 37
Page 2 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.